Principal Investigator
Enrollment Status
Clinical Trial ID
Clinical Trial Summary
The objective of this study is to demonstrate the safety and efficacy of the Penumbra SMART
COIL® System, including the WAVE™ Extra Soft Coils (WAVE) as a fill and finish coil, in the
treatment of intracranial aneurysms. Imaging will be analyzed by an independent core lab to
assess aneurysm occlusion rates and perform a comparative analysis between imaging
modalities.
Phase
N/A
Funding Agency/Sponsor
Industry
Disease
Endovascular
Enrollment Eligibility
Inclusion Criteria:
- Patient age ≥ 18 years
- Patient having embolization of intracranial aneurysms
- WAVE Extra Soft Coil is final finishing coil
- Penumbra SMART COIL System accounts for at least 75% of total number of coils
implanted
- Informed consent obtained per IRB/EC requirements
Exclusion Criteria:
- Life expectancy less than 1 year
- Patient previously enrolled in the SURF Study
- Known multiple intracranial aneurysms requiring treatment during index procedure
- Patient is unwilling or unable to comply with protocol follow up schedule and/or based
on the Investigator's judgment the patient is not a good study candidate
- Participation in an interventional drug or device study that may confound the results
of the study